Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
z-guggulsterone is a plant-derived sterol found in the gum resin of the *Commiphora mukul* tree, traditionally used in Ayurvedic medicine. It acts as a potent antagonist of the Farnesoid X Receptor (FXR), a nuclear receptor involved in bile acid metabolism and immune regulation. Recent research, including studies presented at AACR 2025, highlights its potential in oncology for inhibiting FXR signaling in tumor-associated myeloid cells, such as myeloid-derived suppressor cells (MDSCs) and M2 macrophages. By blocking FXR, z-guggulsterone reduces the immunosuppressive activity of these cells, enhances antigen presentation, and promotes anti-tumor T-cell infiltration, thereby delaying tumor progression and improving the efficacy of adoptive T-cell therapies in models like melanoma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on z-guggulsterone.